Share Price:

APNASPENAspen Pharmacare Hldgs13390-70 (-0.52%)
Our Response to Covid
Country Sites

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Financial Results and Integrated Reporting

Financial Results and Presentations

Interim Results

 


Additional Presentations and webcasts

 


Circular to Shareholders & Supporting Documentation (APAC Divestment)

 

Icon

SENS – DISTRIBUTION OF CIRCULAR TO SHAREHOLDERS AND NOTICE OF GENERAL MEETING

1 file(s) 0.00 KB
Download
Icon

Circular to shareholders – 19 March 2026

1 file(s) 0.00 KB
Download
Icon

Aspen Pharmacare Holdings Limited – Memorandum of Incorporation

1 file(s) 0.00 KB
Download
Icon

Aspen Global Incorporated – Constitution

1 file(s) 0.00 KB
Download
Icon

Annual Financial Statements (including Non-IFRS Financial Information) 2023

1 file(s) 0.00 KB
Download
Icon

Annual Financial Statements (Non-IFRS Financial Information) 2024

1 file(s) 0.00 KB
Download
Icon

Annual Financial Statements (Non-IFRS Financial Information) 2025

1 file(s) 0.00 KB
Download
Icon

Annexure 1 – Combined Historical Financial Information FY 2023, FY 2024 and FY 2025

1 file(s) 0.00 KB
Download
Icon

Annexure 2 – Independent Auditor’s assurance report FY2023, FY2024 and FY 2025

1 file(s) 0.00 KB
Download
Icon

Annexure 3 – Combined Interim Historical Information H1 FY 2026

1 file(s) 0.00 KB
Download
Icon

Annexure 4 – Independent Auditor’s assurance report H1 FY 2026

1 file(s) 0.00 KB
Download
Icon

Annexure 5 – Pro forma financial information

1 file(s) 0.00 KB
Download
Icon

Annexure 6 – Independent Auditor’s assurance Pro forma financial information

1 file(s) 0.00 KB
Download
Icon

Annexure 9 – Independent Auditor’s assurance report(s) on the compilation of the Non-IFRS Financial Information

1 file(s) 0.00 KB
Download
Icon

Paragraph 21 – Advisor consents

1 file(s) 0.00 KB
Download
Icon

Paragraph 11.3 – Summaries of executive director’s employment contracts and non-executive director’s letters of appointment

1 file(s) 0.00 KB
Download
Icon

Paragraph 16 – Irrevocable undertakings

1 file(s) 0.00 KB
Download
Icon

Paragraph 16 – Letters of Support

1 file(s) 0.00 KB
Download

Annual Results

Interim Results

Additional Presentations and webcasts

Annual Results

Interim Results

Additional Presentations and webcasts

Annual Results

 

Interim Results

Annual Results

 

Interim Results

Click here to access prior year Financial Results

Integrated Reporting

Integrated Reporting Suite



Supplementary Documents

Icon

Regional Overviews

1 file(s) 0.00 KB
Download
Icon

Manufacturing Capabilities

1 file(s) 0.00 KB
Download
Icon

B-BBEE Certificate

1 file(s) 0.00 KB
Download

Integrated Reporting Suite

Supplementary Documents

Icon

B-BBEE Certificate

1 file(s) 195.34 KB
Download
Icon

Regional Overviews

1 file(s) 195.34 KB
Download
Icon

Manufacturing Capabilities

1 file(s) 195.34 KB
Download

Integrated Reporting Suite

 

Supplementary Documents

Icon

B-BBEE Certificate

1 file(s) 195.34 KB
Download
Icon

Regional Overviews

1 file(s) 195.34 KB
Download
Icon

Manufacturing Capabilities

1 file(s) 195.34 KB
Download

Integrated Reporting Suite

 

Supplementary Documents

Icon

Modern Slavery Statement

1 file(s) 0.00 KB
Download
Icon

Global Presence

1 file(s) 195.34 KB
Download
Icon

Fact Sheet

1 file(s) 236.28 KB
Download
Icon

Manufacturing Capabilities

1 file(s) 195.34 KB
Download
Icon

Regional Overviews

1 file(s) 195.34 KB
Download
Icon

B-BBEE Certificate

1 file(s) 195.34 KB
Download
Icon

Business Segment Overview

1 file(s) 195.34 KB
Download
Icon

Communication on Progress Report

1 file(s) 195.34 KB
Download

Integrated Reporting Suite

 

Supplementary Documents

Icon

Regional Overview

1 file(s) 1.28 MB
Download
Icon

B-BBEE Certificate

1 file(s) 522.22 KB
Download
Icon

Communication on Progress Report

1 file(s) 1.70 MB
Download

Click here to access 2017 and prior Integrated Reports and Supporting Documents

View FY2023 Online Integrated Report

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD: Switchboard: +27 31 580-8600

Aspen Place, 9 Rydall Vale Park
Douglas Saunders Drive, La Lucia Ridge South Africa

P.O. Box 25125, Gateway, Kwa‑Zulu Natal, 4321, South Africa

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below:

Human Capital
Legal

Supply Chain

Treasury
Ethics & Compliance
Risk & Sustainability
Digital Technology

Tax